GET THE APP

Design, Synthesis, Cytotoxicity and Molecular Docking Studies of Novel Baylis-Hillman Derived 1,2,3-Triazole Derivatives | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Design, Synthesis, Cytotoxicity and Molecular Docking Studies of Novel Baylis-Hillman Derived 1,2,3-Triazole Derivatives

Author(s): Amlipur Santhoshi, Shaik Sadikha, Rakthani Bikshapathi, Chebolu Naga Sesha Sai Pavan Kumar, Sree kanth Sivan

A series of new 1,4-disubstituted 1,2,3-triazole derivatives are synthesized from Baylis-Hillman derived azides in a clean, efficient and simple method. These compounds are assessed for in vitro anticancer activity against six cancer cell lines and some of the compounds exhibited very good activity against different cell lines. Especially, three compounds 8h, 8i and 8j showed potent anticancer activity against prostate adenocarcinoma cancer cell line. Furthermore, molecular docking studies were carried out on DNA and eight different proteins involved in cancer progression to predict the possible molecular target for the synthesized molecule. As per docking results the molecules showed good binding values with respect to Heat Shock Protein and Epidermal Growth Factor Receptor, followed by Tubulin and MEK protein and is least for DNA binding.


Full-Text PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry